Equality in the workplace matters.
Elanco says the deal, which is subject to approval from regulators, would double the size of its companion animal business.
The oncology company has had a strong run and all the technical signals indicate the move higher isn't over.
Let's check out the charts and indicators.
Let's check out the charts and indicators of this medical equipment maker.
Shares of Fitbit were hammered on Thursday after the smartwatch maker lowered expectations for the full year.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.